These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 19809344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM, Buecker A, Wiethoff AJ, Parsons EC, Katoh M, Katsimaglis G, Weisskoff RM, Lauffer RB, Graham PB, Gunther RW, Manning WJ, Spuentrup E.
    Circulation; 2004 Sep 14; 110(11):1463-6. PubMed ID: 15238457
    [Abstract] [Full Text] [Related]

  • 4. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M, Haage P, Wiethoff AJ, Günther RW, Bücker A, Tacke J, Spuentrup E.
    Invest Radiol; 2009 Mar 14; 44(3):146-50. PubMed ID: 19151606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E, Katoh M, Buecker A, Fausten B, Wiethoff AJ, Wildberger JE, Haage P, Parsons EC, Botnar RM, Graham PB, Vettelschoss M, Günther RW.
    Invest Radiol; 2007 Aug 14; 42(8):586-95. PubMed ID: 17620942
    [Abstract] [Full Text] [Related]

  • 7. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.
    Spuentrup E, Botnar RM, Wiethoff AJ, Ibrahim T, Kelle S, Katoh M, Ozgun M, Nagel E, Vymazal J, Graham PB, Günther RW, Maintz D.
    Eur Radiol; 2008 Sep 14; 18(9):1995-2005. PubMed ID: 18425519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular magnetic resonance imaging of atrial clots in a swine model.
    Spuentrup E, Fausten B, Kinzel S, Wiethoff AJ, Botnar RM, Graham PB, Haller S, Katoh M, Parsons EC, Manning WJ, Busch T, Günther RW, Buecker A.
    Circulation; 2005 Jul 19; 112(3):396-9. PubMed ID: 16009790
    [Abstract] [Full Text] [Related]

  • 10. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
    Overoye-Chan K, Koerner S, Looby RJ, Kolodziej AF, Zech SG, Deng Q, Chasse JM, McMurry TJ, Caravan P.
    J Am Chem Soc; 2008 May 07; 130(18):6025-39. PubMed ID: 18393503
    [Abstract] [Full Text] [Related]

  • 11. Suspected early or mild chronic pancreatitis: enhancement patterns on gadolinium chelate dynamic MRI. Magnetic resonance imaging.
    Zhang XM, Shi H, Parker L, Dohke M, Holland GA, Mitchell DG.
    J Magn Reson Imaging; 2003 Jan 07; 17(1):86-94. PubMed ID: 12500277
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E, Ruhl KM, Botnar RM, Wiethoff AJ, Buhl A, Jacques V, Greenfield MT, Krombach GA, Günther RW, Vangel MG, Caravan P.
    Circulation; 2009 Apr 07; 119(13):1768-75. PubMed ID: 19307474
    [Abstract] [Full Text] [Related]

  • 14. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
    Leyendecker JR, Gakhal M, Elsayes KM, McDermott R, Narra VR, Brown JJ.
    J Comput Assist Tomogr; 2008 Apr 07; 32(2):178-84. PubMed ID: 18379298
    [Abstract] [Full Text] [Related]

  • 15. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 16. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.
    Andia ME, Saha P, Jenkins J, Modarai B, Wiethoff AJ, Phinikaridou A, Grover SP, Patel AS, Schaeffter T, Smith A, Botnar RM.
    Arterioscler Thromb Vasc Biol; 2014 Jun 13; 34(6):1193-1198. PubMed ID: 24723557
    [Abstract] [Full Text] [Related]

  • 17. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun 13; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 18. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T.
    J Magn Reson Imaging; 2009 Mar 13; 29(3):636-40. PubMed ID: 19243060
    [Abstract] [Full Text] [Related]

  • 19. Time-resolved dynamic contrast-enhanced MR urography for the evaluation of ureteral peristalsis: initial experience.
    Kim S, Jacob JS, Kim DC, Rivera R, Lim RP, Lee VS.
    J Magn Reson Imaging; 2008 Nov 13; 28(5):1293-8. PubMed ID: 18972340
    [Abstract] [Full Text] [Related]

  • 20. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
    Stracke CP, Katoh M, Wiethoff AJ, Parsons EC, Spangenberg P, Spüntrup E.
    Stroke; 2007 May 13; 38(5):1476-81. PubMed ID: 17379818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.